Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02486562 · ClinicalTrials.gov registry record
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
A clinical trial of Multiple Sclerosis, sponsored by Accelerated Cure Project for Multiple Sclerosis.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 1
- Study location
NCT02486562: Recruiting study of Multiple Sclerosis, sponsored by Accelerated Cure Project for Multiple Sclerosis.
NCT02486562 is a study of Multiple Sclerosis that is actively recruiting participants, run by Accelerated Cure Project for Multiple Sclerosis. The registered enrollment target is 20,000 participants, above the 522-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (3731% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02486562, a study of Multiple Sclerosis, is actively recruiting participants, sponsored by Accelerated Cure Project for Multiple Sclerosis.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 1
- Study location
Study Summary
iConquerMS™ is a research initiative developed by and for people with multiple sclerosis (MS) to contribute their health data and ideas to advance and accelerate research into MS. iConquerMS welcomes adults with MS and others interested in advancing MS research, children and teens with MS and their family members (via iConquerMS Kids \& Teens) and MS caregivers (via iConquerMS Caregivers) to participate.
Conditions Studied
Study Locations (1)
Massachusetts
- Accelerated Cure Project - Waltham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2014-11 |
| Est. Completion | 2036-10 |
What NCT02486562 shows while recruiting
NCT02486562 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 522-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (3731% higher).
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT02486562 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02486562 about?
NCT02486562 is a clinical study titled "IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis". iConquerMS™ is a research initiative developed by and for people with multiple sclerosis (MS) to contribute their health data and ideas to advance and accelerate research into MS. iConquerMS welcomes adults with MS and others interested in advancing MS research, children and teens with MS and their ...
What is the current status of trial NCT02486562?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2014-11. Estimated completion is 2036-10.
What conditions does trial NCT02486562 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
Who is sponsoring clinical trial NCT02486562?
This trial is sponsored by Accelerated Cure Project for Multiple Sclerosis, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02486562 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02486562's enrollment target sits among peer trials
20,000 2nd of 315 the highest of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia